
The Epigenetic Equation
Dementia Researcher Vodcast
09/15/24
•61m
About
Comments
Featured In
In this episode of the Dementia Researcher Podcast, guest host Dr Fiona McLean is joined by Dr Josh Harvey (University of Exeter), Dr Sarah Marzi (King’s College London - UK Dementia Research institute), Dr Alexi Nott (Imperial College London - UK Dementia Research institute), and Dr Sam Washer (Wellcome Trust Sanger Institute) to discuss the role of epigenetics in Alzheimer’s and dementia research.
The episode offers a broad exploration of epigenetics in neurodegenerative diseases, highlighting how gene regulation beyond DNA sequences is advancing our understanding of Alzheimer’s and related conditions. It covers the impact of environmental and lifestyle factors on disease development, as well as emerging research techniques and technologies that could inform future diagnostic and therapeutic approaches.
Key Topics:
- The fundamentals of epigenetics and its distinction from traditional genetics.
- How epigenetic research is shaping our understanding of Alzheimer's disease.
- The role of environmental factors in influencing epigenetic changes.
- New technologies and their application in epigenetic studies.
- The potential for epigenetics in developing future diagnostics and therapies for neurodegenerative diseases.
--
A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.
If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.
Leave us a tip:
https://dementia-researcher.captivate.fm/support
Follow us on social media:
- https://www.instagram.com/dementia_researcher/
- https://www.facebook.com/Dementia.Researcher/
- https://www.twitter.com/demrescommunity
- https://www.linkedin.com/company/dementia-researcher
- https://bsky.app/profile/dementiaresearcher.bsky.social
Download and Register with our Community App:
https://www.onelink.to/dementiaresearcher
We gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.
The views and opinions expressed by guests in this podcast are their own and do not necessarily reflect those of the producers, funders, or sponsors.
Subscribe to our sister show 'Dementia Researcher The Blogs':
Previous Episode

Prioritising People in Co-Produced Research
September 1, 2024
•48m
In this episode of the Dementia Researcher podcast, Dr Anna Volkmer leads a discussion on the importance of co-production in dementia research.
This episode explores what it truly means to involve people with lived experience, with tips on how to go about it, and our guests own experience in working together. They also discuss the research process and how this approach can lead to more relevant and impactful outcomes.
Guests:
- Dr Barbora Silarova: An NIHR / Alzheimer’s Society Dem Comm Fellow at the University of Kent. Barbora brings her expertise in supporting people living with dementia and their carers. She shares insights on the significance of equal partnerships in co-produced research and the challenges and rewards of this collaborative approach.
- Dr Rosie Ashworth: A researcher who leads patient and public involvement for the NRS Neuroprogressive and Dementia Network in Scotland. Rosie discusses the importance of involving those with lived experience in research to enrich the quality and relevance of scientific findings.
- Winnie Henry: A retired psychotherapist who cared for her husband with vascular dementia. Winnie provides a personal perspective on the value of co-production, emphasising empathy and the importance of ensuring that carers' voices are heard in research.
- Mike Parish: A retired firefighter who became a carer for his husband, who had progressive supranuclear palsy. Mike highlights the importance of representing diverse experiences and backgrounds in dementia research to ensure all voices are considered.
- David Ross: A retired engineer who cared for his wife with frontotemporal dementia. David speaks about his journey into co-production, driven by a desire to understand more about dementia and contribute to meaningful research that reflects the realities faced by carers.
Together, these guests provide valuable insights into the process and benefits of co-produced research, offering practical tips for researchers looking to adopt this approach.
Three key take-aways from the podcast:
- The Value of Co-Production in Research: Co-production in dementia research ensures that the perspectives of those with lived experiences, such as unpaid carers and people directly affected by dementia, are central to the research process. This approach not only enhances the relevance and impact of the findings but also addresses the real needs of the community involved.
- Challenges and Rewards of Co-Produced Research: While co-produced research can be more time-consuming and challenging, particularly due to the need for ongoing communication and managing diverse viewpoints, it is ultimately more rewarding. The involvement of people with lived experience leads to more comprehensive and empathetic research outcomes, fostering a deeper connection and mutual respect between researchers and participants.
- Practical Tips for Researchers: Effective co-production requires empathy, flexibility, and open communication. Researchers are encouraged to build strong relationships with participants, be willing to adapt to different needs, and ensure that everyone involved feels valued and heard. This collaborative approach can transform the research process, making it more inclusive and impactful.
--
A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.
If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.
Leave us a tip:
Next Episode

ISFTD 2024 Conference Highlights
September 29, 2024
•49m
In this podcast we bring you highlights from the International Society for Frontotemporal Dementias (ISFD) Conference, which was held in Amsterdam from the 19th to 22nd September 2024.
Dr Anna Volkmer talks with Dr Martyna Matuszyk from Alzheimer’s Society and Dr Aitana Sogorb Esteve from University College London discussing their highlights and recapping on the event and what they’re taking away from this year’s talks.
- Advancements in FTD Research: Key research on the genetic and molecular mechanisms of frontotemporal dementia, particularly focusing on biomarkers for early diagnosis.
- Novel Therapeutic Approaches: Promising developments in treatments targeting FTD-specific pathology, with potential to improve patient outcomes.
- Challenges in Translating Research to Practice: The complexity of moving lab discoveries into clinical applications, and the need for more streamlined processes.
- Importance of Collaboration: Emphasis on interdisciplinary cooperation to address the multifaceted nature of dementia research.
- Breakthroughs in Neuroimaging: Advances in neuroimaging techniques that could enhance understanding of disease progression and improve diagnostic accuracy.
- Public and Patient Involvement: The vital role of involving patients and the public in shaping research agendas, ensuring that studies address real-world needs.
- Effective Science Communication: The need to translate complex scientific information into accessible language for both the public and other stakeholders.
- Annual ISFTD Conference: Excitement around the announcement that the conference will be held annually starting in 2026, fostering more frequent collaboration and knowledge sharing.
The International Society for Frontotemporal Dementias is a non-profit scientific society focused on frontotemporal dementias. Members include the leaders in FTD research around the world, and the society is associated with a large, international biannual meeting (soon to be annual) presenting the latest findings.
For more information visit: www.isftd.org
--
A transcript of this show, links and show notes and profile on all our guests are available on our website at https://www.dementiaresearcher.nihr.ac.uk.
If you prefer to watch rather than listen, you will find a video version of this podcast on Apple Podcasts, YouTube, and on our website.
Leave us a tip:
https://dementia-researcher.captivate.fm/support
Follow us on social media:
- https://www.instagram.com/dementia_researcher/
- https://www.facebook.com/Dementia.Researcher/
- https://www.twitter.com/demrescommunity
- https://www.linkedin.com/company/dementia-researcher
- https://bsky.app/profile/dementiaresearcher.bsky.social
Download and Register with our Community App:
https://www.onelink.to/dementiaresearcher
We gratefully acknowledge the support of our funders: Alzheimer’s Association, Race Against Dementia, Alzheimer’s Research UK, Alzheimer’s Society, and the National Institute for Health and Care Research.
The views and opinions expressed by guests...
If you like this episode you’ll love
Promoted




